Please login to view this media

- Talk
- 19/09/2023
- UK
BOSTAA - Meniscal Allograft Transplantation: Where Are We In 2023?
Description
In this presentation, Nick Smith discusses the indications for meniscal transplants, outlining both ideal cases, such as patients with recent meniscectomy experiencing activity-related knee pain, and salvage cases involving patients with a longer history post-meniscectomy and compromised chondral surfaces. He highlights the importance of assessing knee alignment, ligament stability, and chondral surface condition before proceeding with a transplant. Three techniques for meniscal transplantation are detailed: soft tissue through bone tunnels, bone plugs, and the bone trough method, with varying degrees of biomechanical support yet showing similar clinical outcomes in practice.
Several patient case examples illustrate the varied presentations and surgical outcomes, emphasizing the complexities of treating younger patients with significant bone damage. Post-operative results typically demonstrate an initial lack of integration that improves over time, showcasing the necessity for follow-up MRIs and patient assessments.
Smith reports on the survival rates of meniscal transplants based on over 500 cases analyzed at his institution, noting that outcomes vary significantly based on the patient's circumstances and pre-existing conditions. The conversation extends to the topic of returning to sports post-surgery, addressing the common inclination among patients to resume high-level athletic activity despite surgical advice against it. In conclusion, a call for referrals to the METEOR2 trial seeking new patients for study participation is made, underscoring the evolving practices in meniscal transplant management.